S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Market Wizard Larry Benedict revealing his best-kept secret for just $29 (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
NASDAQ:PETS

PetMed Express - PETS Stock Forecast, Price & News

$18.77
-0.18 (-0.95%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$18.61
$18.95
50-Day Range
$18.77
$22.31
52-Week Range
$18.22
$29.53
Volume
192,043 shs
Average Volume
397,063 shs
Market Capitalization
$395.60 million
P/E Ratio
24.06
Dividend Yield
6.33%
Price Target
$25.00

PetMed Express MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
33.2% Upside
$25.00 Price Target
Short Interest
Bearish
20.82% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.30mentions of PetMed Express in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
16.00%
From $0.75 to $0.87 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.80 out of 5 stars

Retail/Wholesale Sector

24th out of 218 stocks

Drug Stores & Proprietary Stores Industry

1st out of 6 stocks

PETS stock logo

About PetMed Express (NASDAQ:PETS) Stock

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Stock News Headlines

PetMed Express: Getting Closer, But Not Yet
2 Stocks That Could Surprise Investors in 2023
PetMed Express: Vetster Partnership A Growth Mega Booster
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Company Calendar

Last Earnings
10/24/2021
Ex-Dividend for 11/30 Dividend
11/17/2022
Dividend Payable
11/30/2022
Today
12/09/2022
Next Earnings (Estimated)
1/23/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
219
Year Founded
1996

Price Target and Rating

Average Stock Price Forecast
$25.00
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$18.00
Forecasted Upside/Downside
+33.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$21.10 million
Pretax Margin
7.76%

Debt

Sales & Book Value

Annual Sales
$273.42 million
Cash Flow
$1.17 per share
Book Value
$6.78 per share

Miscellaneous

Free Float
20,212,000
Market Cap
$395.60 million
Optionable
Optionable
Beta
0.56

Social Links


Key Executives

  • Mr. Matthew N. Hulett (Age 51)
    CEO, Pres & Director
    Comp: $498.7k
  • Mr. Bruce S. RosenbloomMr. Bruce S. Rosenbloom (Age 53)
    Treasurer
    Comp: $487.96k
  • Ms. Christine Chambers (Age 45)
    CFO, Principal Financial Officer & Principal Accounting Officer
  • Mr. Mark Moseley
    Chief Technology & Information Officer
  • Mr. Daniel Job Pingree
    Chief Marketing Officer
  • Ms. Jacqueline Smith
    VP of People
  • Wendy Zalai
    Corp. Controller & Corp. Sec.













PETS Stock - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings
or view top-rated stocks.

What is PetMed Express' stock price forecast for 2023?

2 equities research analysts have issued 12 month price objectives for PetMed Express' shares. Their PETS share price forecasts range from $18.00 to $32.00. On average, they predict the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 33.2% from the stock's current price.
View analysts price targets for PETS
or view top-rated stocks among Wall Street analysts.

How have PETS shares performed in 2022?

PetMed Express' stock was trading at $25.26 on January 1st, 2022. Since then, PETS stock has decreased by 25.7% and is now trading at $18.77.
View the best growth stocks for 2022 here
.

When is PetMed Express' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, January 23rd 2023.
View our PETS earnings forecast
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) released its quarterly earnings data on Sunday, October, 24th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.34 by $0.03. The business had revenue of $67.39 million for the quarter, compared to the consensus estimate of $70.90 million. PetMed Express had a net margin of 5.98% and a trailing twelve-month return on equity of 11.17%. During the same period last year, the business earned $0.42 EPS.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express announced a quarterly dividend on Monday, November 7th. Shareholders of record on Friday, November 18th will be given a dividend of $0.30 per share on Wednesday, November 30th. This represents a $1.20 annualized dividend and a dividend yield of 6.39%. The ex-dividend date of this dividend is Thursday, November 17th.
Read our dividend analysis for PETS
.

Is PetMed Express a good dividend stock?

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 6.33%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 153.85%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 137.93% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.67%), Vanguard Group Inc. (7.23%), Renaissance Technologies LLC (4.61%), State Street Corp (4.40%), Dimensional Fund Advisors LP (2.70%) and ProShare Advisors LLC (2.45%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetMed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $18.77.

How much money does PetMed Express make?

PetMed Express (NASDAQ:PETS) has a market capitalization of $395.60 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.78 on an earnings per share basis.

How many employees does PetMed Express have?

The company employs 219 workers across the globe.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.

This page (NASDAQ:PETS) was last updated on 12/10/2022 by MarketBeat.com Staff